Autophagy suppresses RIP kinase-dependent necrosis enabling survival to mTOR inhibition

Kevin Bray, Robin Mathew, Alexandria Lau, Jurre J. Kamphorst, Jing Fan, Jim Chen, Hsin Yi Chen, Anahita Ghavami, Mark Stein, Robert S. DiPaola, Donna Zhang, Joshua D. Rabinowitz, Eileen White

Research output: Contribution to journalArticle

87 Citations (Scopus)

Abstract

mTOR inhibitors are used clinically to treat renal cancer but are not curative. Here we show that autophagy is a resistance mechanism of human renal cell carcinoma (RCC) cell lines to mTOR inhibitors. RCC cell lines have high basal autophagy that is required for survival to mTOR inhibition. In RCC4 cells, inhibition of mTOR with CCI-779 stimulates autophagy and eliminates RIP kinases (RIPKs) and this is blocked by autophagy inhibition, which induces RIPK- and ROS-dependent necroptosis in vitro and suppresses xenograft growth. Autophagy of mitochondria is required for cell survival since mTOR inhibition turns off Nrf2 antioxidant defense. Thus, coordinate mTOR and autophagy inhibition leads to an imbalance between ROS production and defense, causing necroptosis that may enhance cancer treatment efficacy.

Original languageEnglish (US)
Article numbere41831
JournalPLoS One
Volume7
Issue number7
DOIs
StatePublished - Jul 26 2012

Fingerprint

autophagy
Autophagy
necrosis
phosphotransferases (kinases)
Necrosis
Phosphotransferases
Cells
Survival
kidney cells
Renal Cell Carcinoma
Mitochondria
carcinoma
Oncology
cell lines
Heterografts
kidney neoplasms
Cell Line
Antioxidants
Kidney Neoplasms
resistance mechanisms

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Bray, K., Mathew, R., Lau, A., Kamphorst, J. J., Fan, J., Chen, J., ... White, E. (2012). Autophagy suppresses RIP kinase-dependent necrosis enabling survival to mTOR inhibition. PLoS One, 7(7), [e41831]. https://doi.org/10.1371/journal.pone.0041831

Autophagy suppresses RIP kinase-dependent necrosis enabling survival to mTOR inhibition. / Bray, Kevin; Mathew, Robin; Lau, Alexandria; Kamphorst, Jurre J.; Fan, Jing; Chen, Jim; Chen, Hsin Yi; Ghavami, Anahita; Stein, Mark; DiPaola, Robert S.; Zhang, Donna; Rabinowitz, Joshua D.; White, Eileen.

In: PLoS One, Vol. 7, No. 7, e41831, 26.07.2012.

Research output: Contribution to journalArticle

Bray, K, Mathew, R, Lau, A, Kamphorst, JJ, Fan, J, Chen, J, Chen, HY, Ghavami, A, Stein, M, DiPaola, RS, Zhang, D, Rabinowitz, JD & White, E 2012, 'Autophagy suppresses RIP kinase-dependent necrosis enabling survival to mTOR inhibition', PLoS One, vol. 7, no. 7, e41831. https://doi.org/10.1371/journal.pone.0041831
Bray, Kevin ; Mathew, Robin ; Lau, Alexandria ; Kamphorst, Jurre J. ; Fan, Jing ; Chen, Jim ; Chen, Hsin Yi ; Ghavami, Anahita ; Stein, Mark ; DiPaola, Robert S. ; Zhang, Donna ; Rabinowitz, Joshua D. ; White, Eileen. / Autophagy suppresses RIP kinase-dependent necrosis enabling survival to mTOR inhibition. In: PLoS One. 2012 ; Vol. 7, No. 7.
@article{ffe1e16f9c3c46b0bbbbea62636e46dc,
title = "Autophagy suppresses RIP kinase-dependent necrosis enabling survival to mTOR inhibition",
abstract = "mTOR inhibitors are used clinically to treat renal cancer but are not curative. Here we show that autophagy is a resistance mechanism of human renal cell carcinoma (RCC) cell lines to mTOR inhibitors. RCC cell lines have high basal autophagy that is required for survival to mTOR inhibition. In RCC4 cells, inhibition of mTOR with CCI-779 stimulates autophagy and eliminates RIP kinases (RIPKs) and this is blocked by autophagy inhibition, which induces RIPK- and ROS-dependent necroptosis in vitro and suppresses xenograft growth. Autophagy of mitochondria is required for cell survival since mTOR inhibition turns off Nrf2 antioxidant defense. Thus, coordinate mTOR and autophagy inhibition leads to an imbalance between ROS production and defense, causing necroptosis that may enhance cancer treatment efficacy.",
author = "Kevin Bray and Robin Mathew and Alexandria Lau and Kamphorst, {Jurre J.} and Jing Fan and Jim Chen and Chen, {Hsin Yi} and Anahita Ghavami and Mark Stein and DiPaola, {Robert S.} and Donna Zhang and Rabinowitz, {Joshua D.} and Eileen White",
year = "2012",
month = "7",
day = "26",
doi = "10.1371/journal.pone.0041831",
language = "English (US)",
volume = "7",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "7",

}

TY - JOUR

T1 - Autophagy suppresses RIP kinase-dependent necrosis enabling survival to mTOR inhibition

AU - Bray, Kevin

AU - Mathew, Robin

AU - Lau, Alexandria

AU - Kamphorst, Jurre J.

AU - Fan, Jing

AU - Chen, Jim

AU - Chen, Hsin Yi

AU - Ghavami, Anahita

AU - Stein, Mark

AU - DiPaola, Robert S.

AU - Zhang, Donna

AU - Rabinowitz, Joshua D.

AU - White, Eileen

PY - 2012/7/26

Y1 - 2012/7/26

N2 - mTOR inhibitors are used clinically to treat renal cancer but are not curative. Here we show that autophagy is a resistance mechanism of human renal cell carcinoma (RCC) cell lines to mTOR inhibitors. RCC cell lines have high basal autophagy that is required for survival to mTOR inhibition. In RCC4 cells, inhibition of mTOR with CCI-779 stimulates autophagy and eliminates RIP kinases (RIPKs) and this is blocked by autophagy inhibition, which induces RIPK- and ROS-dependent necroptosis in vitro and suppresses xenograft growth. Autophagy of mitochondria is required for cell survival since mTOR inhibition turns off Nrf2 antioxidant defense. Thus, coordinate mTOR and autophagy inhibition leads to an imbalance between ROS production and defense, causing necroptosis that may enhance cancer treatment efficacy.

AB - mTOR inhibitors are used clinically to treat renal cancer but are not curative. Here we show that autophagy is a resistance mechanism of human renal cell carcinoma (RCC) cell lines to mTOR inhibitors. RCC cell lines have high basal autophagy that is required for survival to mTOR inhibition. In RCC4 cells, inhibition of mTOR with CCI-779 stimulates autophagy and eliminates RIP kinases (RIPKs) and this is blocked by autophagy inhibition, which induces RIPK- and ROS-dependent necroptosis in vitro and suppresses xenograft growth. Autophagy of mitochondria is required for cell survival since mTOR inhibition turns off Nrf2 antioxidant defense. Thus, coordinate mTOR and autophagy inhibition leads to an imbalance between ROS production and defense, causing necroptosis that may enhance cancer treatment efficacy.

UR - http://www.scopus.com/inward/record.url?scp=84864389175&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864389175&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0041831

DO - 10.1371/journal.pone.0041831

M3 - Article

C2 - 22848625

AN - SCOPUS:84864389175

VL - 7

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 7

M1 - e41831

ER -